Hims & Hers responds to FTC lawsuit
The company states the FTC disregarded evidence and will vigorously defend itself.
See the latest news and media coverage for Hims. We track all announcements, press releases, and industry mentions in real time, all in one place.
Men's health telehealth provider
hims.comLast updated
In short: Hims expanded its global footprint and weight-loss offerings while navigating regulatory shifts and legal challenges in the peptide market.
The company states the FTC disregarded evidence and will vigorously defend itself.
The company outlines its transparency, data safeguards, and user choice tools.
Dr. Vinjamoori argues that banning peptides drives demand to unsafe gray markets and advocates for supervised compounding based on real-world evidence.
She will leave effective October 9, 2026, and serve as an advisor for the transition.
Though new privacy actions under the FTC Act might be rare these days, best practices for health-related data haven't changed.
LOS ANGELES , July 31, 2026 /PRNewswire/ -- Schall, Brown & Schwartz LLP ("SBS"), a national...
Regulators accuse the telehealth company of sharing sensitive health information with advertising platforms including Meta and Snap despite promising users privacy.
The Federal Trade Commission, along with two states, California and Utah, is suing the popular telehealth company Hims & Hers. The commission alleges the company...
Track Hims and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Hims and other trending companies.